There was no significant enrichment of BCR sequences with known binding to viral or bacterial antigens in these four clonal categories, indicating that these were not enriched for established systemic responses to non-cancer antigens and, therefore, did not just represent re-expansions of non-tumor-specific B cell clones (Extended Data Fig. 4b, Supplementary Table 3 and Methods). This evidence concerns the gene BCR and cancer.